About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Open-Label Study of ARD-0403 in Testosterone Deficient Men

NCT00562731·12 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Ardana Bioscience Ltd

Age

18–any

Sex

MALE

Healthy volunteers

Not accepted

You may be eligible if

Testosterone deficiency
Completed study ARD-0403-004

You may not be if

Previous treatment with testosterone replacement therapy within 4 weeks
Moderate-severe benign prostatic hypertrophy or prostatic cancer
Haematocrit \>50%

The record

StatusTerminated

PhasePhase 3

Taking part150

StartedOct 2007

UpdatedApr 1, 2008

Conditions

Where12

Medical Affiliated Research Center, Inc
Huntsville, Alabama, United States
Stanford University
Stanford, California, United States
Harbor-UCLA Medical Center
Torrance, California, United States

Clareo Health | Open-Label Study of ARD-0403 in Testosterone Deficient Men